By Elena Vasquez

Veterinary advocates have set two federal priorities for the next Congress, scheduling xylazine as a controlled drug and rewriting the tax code for rural loan repayment, AVMA reporting shows. The two-pronged push reflects the dual pressure practitioners face from street-drug diversion of legitimate pharmaceuticals and from chronic staffing gaps in counties with few referral centers.

What is at stake with xylazine scheduling?

Xylazine, an alpha-2 adrenergic agonist the FDA Center for Veterinary Medicine approved for sedation, analgesia, and muscle relaxation in non-food animals, has migrated into the illicit drug supply as a fentanyl adulterant. Forensic toxicology first surfaced xylazine in seized fentanyl samples in the early 2020s. The drug has since spread into most U.S. regional drug supplies.

The White House Office of National Drug Control Policy designated xylazine an emerging drug threat in April 2023. The same month, the FDA moved to restrict unlawful finished dosage forms through import alerts and enforcement guidance. No federal scheduling under the Controlled Substances Act has followed.

The AVMA position seeks DEA scheduling language that curbs diversion without strangling clinical use. Practitioners depend on xylazine for chemical restraint in dogs, cats, horses, and wildlife; the drug also appears in approved compounded formulations for diagnostic imaging and minor procedures. Any schedule must preserve veterinary supply, pricing, and procurement.

Practitioner takeaway: the regulatory design will decide whether sedation protocols in your clinic face new recordkeeping, storage, or prescribing requirements within months, not years.

Why is the rural workforce a federal issue?

Rural veterinary shortages have widened for more than a decade. Food-animal practice in counties distant from referral centers often lacks the caseload to support recent graduates carrying six-figure student debt. USDA has long maintained a Veterinary Medicine Loan Repayment Program that places practitioners in shortage areas, but awards count as taxable income to recipients. The federal lever most often cited is excluding those payments from gross income.

Federal legislation introduced in prior Congresses would do exactly that, mirroring physician loan-forgiveness treatment under the National Health Service Corps. The AVMA push now seeks to re-introduce or advance such language and to secure USDA appropriations for rural practice grants, telemedicine infrastructure, and expanded VMLRP placements.

Practitioner takeaway: the tax fix does not reach your paycheck tomorrow, but it changes who can afford to practice in your county five years from now.

What changes at the exam table and in the barn?

• Companion-animal practitioners: xylazine scheduling could add DEA registration, controlled-drug logbooks, and disposal requirements for sedatives already on your shelf, depending on the schedule level proposed.
• Food-animal and equine practitioners: any scheduling language must explicitly cover approved species indications to avoid disrupting bovine, cervid, or equine sedation in the field.
• Public-health and shelter medicine: xylazine's human-use pathology (skin necrosis, prolonged sedation, bradycardia, overdose complications) ties veterinary policy directly to street-drug response and to first-responder protocols.
• Mixed-animal rural practitioners: a tax fix on loan repayment would alter recruitment pipelines at the clinic that hires you, even if you carry no loans yourself.

What's next on the federal calendar?

Whether the AVMA push moves from statement to statute depends on committee markups in the next Congress and on DEA scheduling initiation. Practitioners who use xylazine weekly should monitor the Federal Register and DEA scheduling announcements for proposed rules. The veterinary community should weigh in during any DEA comment window.

Federal action on the workforce side requires either a tax bill or an appropriations vehicle. Neither vehicle is guaranteed in a divided Congress. The agenda is on the table, and the next election cycle will set the timeline for either movement.